Donor lymphocyte infusion after allogeneic haematopoietic cell transplantation for haematological malignancies: basic considerations and best practice …
S Pagliuca, C Schmid, N Santoro… - The Lancet …, 2024 - thelancet.com
Since the early description of three patients with relapsed leukaemia after allogeneic
haematopoietic cell transplantation (HCT) who obtained complete remission after donor …
haematopoietic cell transplantation (HCT) who obtained complete remission after donor …
Toxicités hématologiques après CAR-T cells, recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)
T Alsuliman, C Aubrun, JO Bay, Y Beguin… - Bulletin du …, 2024 - Elsevier
Résumé Les chimeric antigen receptor T cells/cellules T à récepteur antigénique chimérique
(CAR-T cells) représentent un traitement prometteur pour la prise en charge de plusieurs …
(CAR-T cells) représentent un traitement prometteur pour la prise en charge de plusieurs …
[PDF][PDF] Studies on Photophysical and Biological Activity of Newly Synthesized of 4-Methylpiperidin-4-ol Substituted Pyrazole Derivatives
GH Al-Hazmi, V Marrakkur, L Naik, MS Refat - Polish Journal of Environmental … - pjoes.com
(FHM) have been evaluated in the current work. The addition of 4-methylpiperidin-4-ol,
which increases the molecule's lipid solubility and speeds up absorption by increasing its …
which increases the molecule's lipid solubility and speeds up absorption by increasing its …